Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02533622 · ClinicalTrials.gov registry record
Holy Name Progressive Mobility in the ICU
A clinical trial, sponsored by Hill-Rom.
- Completed
- Registry status
- 63
- Enrollment target
NCT02533622: Completed study, sponsored by Hill-Rom.
NCT02533622 is a clinical trial that has completed, run by Hill-Rom. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02533622 has completed, sponsored by Hill-Rom.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
Despite the known complications of immobility for ICU patients, compliance to mobility protocols is lacking in many institutions. Significant barriers have been described to compliance to up in chair and weight bearing orders in the ICU. Recent studies indicate that if progressive mobility is performed for acutely ill ICU patients they may have a reduced ICU length of stay, reduced overall hospital length of stay, incur lower hospital costs, and reduce the rate of some medical complications and increase functionality post ICU discharge. The current protocol seeks to understand whether or not the TotalCare® P500 Bed System and the Liko Lift can remove some of the barriers associated with progressive mobility compliance.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-01 |
What the finished NCT02533622 record still lists
NCT02533622 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02533622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02533622 about?
NCT02533622 is a clinical study titled "Holy Name Progressive Mobility in the ICU". Despite the known complications of immobility for ICU patients, compliance to mobility protocols is lacking in many institutions. Significant barriers have been described to compliance to up in chair and weight bearing orders in the ICU. Recent studies indicate that if progressive mobility is perfor...
What is the current status of trial NCT02533622?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2011-01. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT02533622?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia